Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study

BACKGROUND: There is a need to establish an effective neoadjuvant therapy for soft tissue sarcomas (STSs). We previously showed that apatinib, administered in combination with doxorubicin-based chemotherapy, improves the efficacy of treatment. This study aimed to clarify the effectiveness and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zhichao, Wang, Jiaqiang, Yang, Jinpo, Zhang, Peng, Wang, Xin, Zhang, Fan, Li, Po, Yao, Weitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541966/
https://www.ncbi.nlm.nih.gov/pubmed/34156595
http://dx.doi.org/10.1007/s10637-021-01139-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541966/
https://www.ncbi.nlm.nih.gov/pubmed/34156595
http://dx.doi.org/10.1007/s10637-021-01139-w

Ejemplares similares